Rosemount senior Nate Beyer wrestles for the Irish despite being diagnosed with Leber's Hereditary Optic Neuropathy (LHON).
A one-time injection of Lumevoq demonstrated sustained visual acuity improvements with a favorable safety profile at 5 years ...
GenSight Biologics announces efficacy and safety results for Lumevoq gene therapy at the conclusion of the REFLECT phase III clinical study: Paris Thursday, February 13, 2025, 17: ...
The five-year trial saw patients who received a single injection of Lumevoq sustaining clinical recovery in a rare condition ...
Brent Devloo says his iPad is the reason he was able to graduate high school after he suddenly became blind in the 11th grade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results